Mukenge E, Sumbu B, Nkodila A, Muwonga J, Makulo J, Ngole M
BMC Infect Dis. 2025; 25(1):342.
PMID: 40069636
PMC: 11899428.
DOI: 10.1186/s12879-025-10754-4.
Dwivedi T, Raj A, Das N, Gupta R, Bhatnagar S, Mohan A
Indian J Clin Biochem. 2025; 40(1):111-120.
PMID: 39835239
PMC: 11741955.
DOI: 10.1007/s12291-023-01149-w.
Vilela L, Silva A, Cruz A, Sousa M, Costa M, Fonseca F
Vaccines (Basel). 2025; 12(12.
PMID: 39772020
PMC: 11680130.
DOI: 10.3390/vaccines12121358.
Pinto P, Timis J, Chuensirikulchai K, Li Q, Lu H, Maule E
NPJ Vaccines. 2024; 9(1):252.
PMID: 39702529
PMC: 11659323.
DOI: 10.1038/s41541-024-01043-3.
Cai Z, Ni W, Li W, Wu Z, Yao X, Zheng Y
J Virol. 2024; 99(1):e0151624.
PMID: 39699185
PMC: 11784297.
DOI: 10.1128/jvi.01516-24.
Symptomatology and IgG Levels before and after SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals.
Paula N, Joucoski E, Baura V, Souza E, Pedrosa F, Goncalves A
Vaccines (Basel). 2024; 12(10).
PMID: 39460316
PMC: 11512233.
DOI: 10.3390/vaccines12101149.
Time-course analysis of antibody and cytokine response after the third SARS-CoV-2 vaccine dose.
Kim H, Lee H, Hennighausen L, Furth P, Sung H, Huh J
Vaccine X. 2024; 20:100565.
PMID: 39399820
PMC: 11470517.
DOI: 10.1016/j.jvacx.2024.100565.
Post COVID-19 vaccination binding and neutralizing antibody with or without previous infection: An 18-month longitudinal study in Indonesia.
Ardyanto T, Khariri K, Agus T, Soebandrio A
Narra J. 2024; 4(2):e1071.
PMID: 39280276
PMC: 11394176.
DOI: 10.52225/narra.v4i2.1071.
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization.
Moghnieh R, Haddad W, Jbeily N, El-Hassan S, Eid S, Baba H
PLoS One. 2024; 19(9):e0306457.
PMID: 39269963
PMC: 11398646.
DOI: 10.1371/journal.pone.0306457.
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.
Aiello A, Ruggieri S, Navarra A, Tortorella C, Vanini V, Haggiag S
Vaccines (Basel). 2024; 12(8).
PMID: 39204049
PMC: 11359508.
DOI: 10.3390/vaccines12080926.
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients.
Almeida B, Dias T, Cruz P, Sousa-Pimenta M, Teixeira A, Pereira C
Vaccines (Basel). 2024; 12(8).
PMID: 39203974
PMC: 11359428.
DOI: 10.3390/vaccines12080848.
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants.
Metzdorf K, Jacobsen H, Kim Y, Teixeira Alves L, Kulkarni U, Cokaric Brdovcak M
Front Immunol. 2024; 15:1383086.
PMID: 39119342
PMC: 11306140.
DOI: 10.3389/fimmu.2024.1383086.
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data.
Claus J, Ten Doesschate T, Taks E, Debisarun P, Smits G, van Binnendijk R
Vaccines (Basel). 2024; 12(6).
PMID: 38932420
PMC: 11209274.
DOI: 10.3390/vaccines12060691.
Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls.
Nemeth D, Vago H, Tothfalusi L, Ulakcsai Z, Becker D, Szabo Z
Front Immunol. 2024; 15:1397052.
PMID: 38911866
PMC: 11190160.
DOI: 10.3389/fimmu.2024.1397052.
Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland.
Macdonald C, Palmateer N, McAuley A, Lindsay L, Hasan T, Hameed S
NPJ Vaccines. 2024; 9(1):107.
PMID: 38877008
PMC: 11178861.
DOI: 10.1038/s41541-024-00898-w.
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients.
Konuma T, Hamatani-Asakura M, Nagai E, Adachi E, Kato S, Isobe M
Int J Hematol. 2024; 120(2):229-240.
PMID: 38842630
PMC: 11284193.
DOI: 10.1007/s12185-024-03802-3.
SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Responses after ChAdOx1 nCoV-19 Vaccination in Solid Organ Transplant Recipients.
Phornkittikorn P, Kantachuvesiri S, Sobhonslidsuk A, Yingchoncharoen T, Kiertiburanakul S, Bruminhent J
Vaccines (Basel). 2024; 12(5).
PMID: 38793792
PMC: 11125913.
DOI: 10.3390/vaccines12050541.
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh.
Haq M, Roy A, Ahmed R, Kuddusi R, Sinha M, Hossain M
Sci Rep. 2024; 14(1):11467.
PMID: 38769324
PMC: 11106241.
DOI: 10.1038/s41598-024-61922-6.
The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
Hwang L, Vaithilingam S, Ng J, Nair M, Ahmed P, Musa K
PLoS One. 2024; 19(4):e0301383.
PMID: 38687718
PMC: 11060549.
DOI: 10.1371/journal.pone.0301383.
Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients.
Dhaliwal J, Sekhon M, Rajotia A, Dang A, Singh P, Bilal M
Medicina (Kaunas). 2024; 60(4).
PMID: 38674243
PMC: 11052327.
DOI: 10.3390/medicina60040597.
